Management of biochemically recurrent prostate cancer: molecular imaging perspective
Letter to the Editor
First Online:
Received:
Accepted:
- 69 Downloads
Notes
Compliance with ethical standards
Conflict of interest
The author declares that they have no conflict of interest.
References
- 1.Toussi A, Stewart-Merrill SB, Boorjian SA et al (2016) Standardizing the definition of biochemical recurrence after radical prostatectomy—what prostate specific antigen cut point best predicts a durable increase and subsequent systemic progression? Urology 195(6):1754–1759CrossRefGoogle Scholar
- 2.Bouchelouche K, Tagawa ST, Goldsmith SJ et al (2011) PET/CT imaging and radioimmunotherapy of prostate cancer. Semin Nucl Med 41(1):29–44CrossRefPubMedPubMedCentralGoogle Scholar
- 3.Giesel FL, Kesch C, Yun M et al (2017) 18F-PSMA-1007 PET/CT detects micrometastases in a patient with biochemically recurrent prostate cancer. Clin Genitourin Cancer 15(3):e497–e499CrossRefPubMedGoogle Scholar
- 4.Martinez-Lorca A (2016) The challenge of adequate metastasis detection in the patient with castration-resistant prostate cancer. Rev Mex Urol 76:129–130CrossRefGoogle Scholar
Copyright information
© Springer-Verlag GmbH Germany, part of Springer Nature 2017